These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 33360025)

  • 1. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
    Thepmankorn P; Bach J; Lasfar A; Zhao X; Souayah S; Chong ZZ; Souayah N
    Cytokine; 2021 Feb; 138():155404. PubMed ID: 33360025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
    Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
    J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological Complications of COVID-19: Underlying Mechanisms and Management.
    Shehata GA; Lord KC; Grudzinski MC; Elsayed M; Abdelnaby R; Elshabrawy HA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report.
    Satheesh NJ; Salloum-Asfar S; Abdulla SA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and its effects on neurological functions.
    Yew MMT; Lip JQ; Ling APK
    Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological manifestations of COVID-19: A brief review.
    Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
    Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
    Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection.
    Jagst M; Pottkämper L; Gömer A; Pitarokoili K; Steinmann E
    Curr Opin Microbiol; 2024 Jun; 79():102474. PubMed ID: 38615394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological complications and infection mechanism of SARS-COV-2.
    Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on neurological manifestations of COVID-19.
    Yavarpour-Bali H; Ghasemi-Kasman M
    Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
    Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M
    Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.